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Vitamin D3 is a crucial co-regulator of bone growth and remodeling, neuromuscular
function, inflammation, proliferation, differentiation and apoptosis of cells. Intensive
research on endogenous sulfur metabolism has revealed that hydrogen sulfide (H2S) is animportant modulator of various physiological processes in mammals. Noteworthy, these
compounds are perceived as potential agents in the treatment of numerous disorders,
including cardiovascular diseases and different types of cancer. The interaction between
vitamin D3 and H2S is unknown. The aim of the study is to assess the influence ofcholecalciferol (vitamin D3, calcitriol) on H2S tissue concentrations in mouse brain, heartand kidney. Twenty four SJL mice were given intraperitoneal injections of cholecalciferol at
10000 IU/kg body weight (b.w.) per day (group A, n = 8) or 40000 IU/kg b.w. per day (group
B, n = 8). The control group (n = 8) received physiological saline. Free H2S tissueconcentrations were measured via the SIEGEL spectrophotometric modified method. There
was a significant progressive increase in the H2S concentration along with the risingcholecalciferol doses as compared to the control group in the heart (by 29.6% and by 74.1%,
respectively). Higher vitamin D3 dose caused H2S accumulation in the brain (by 10.9%) andin the kidney (by 10.1%). Our study has proven that cholecalciferol affects H2S tissueconcentration in different mouse organs.
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Vitamin D is a group of fat-soluble secosteroids
known for years to be implicated in the regulation
of calcium and phosphate homeostasis. Interest-
ingly, studies in recent decades have shown that
the action of vitamin D3, the most important pleio-
tropic vitamin D form in humans and most verte-
brates, involves other crucial processes such as
modulation of neuromuscular function, inflamma-
tion, proliferation, differentiation and apoptosis of
cells (LISS & FRISHMAN 2012). Analogically, in-
tensive research on endogenous sulfur metabolism
has revealed that hydrogen sulfide (H2S), a dan-
gerous industrial and environmental toxin, is an
important physiological co-regulator in mammals
(KIMURA 2011). What vitamin D3 and H2S have in
common is that they are both perceived as poten-
tial agents in the treatment of disorders of many
branches of medicine, including cardiovascular
diseases and different types of cancer (LEE et al.
2011; PREDMORE & LEFER 2010; WELSH 2012).
The interaction between vitamin D3 (cholecal-
ciferol, calcitriol) and H2S is unknown. The aim of
this study is to assess the influence of cholecalcif-
erol on endogenous H2S concentrations in mouse
brain, heart and kidney tissues.
_______________________________________
*Supported by a grant from the Jagiellonian University Medical College (No. K/ZBW/000175).
Material and Method
Animals
Twenty four SJL male mice (7-8 week old indi-
viduals) weighing approximately 20 g were in-
volved in the study. The animals were housed
under standard laboratory conditions and had free
access to water and food. They were kept at
22-24°C with a light/dark cycle of 12 h.
Study design
An injectable solution of vitamin D3 (Devikap,
Medana Pharma, Poland) was used. Intraperito-
neal injections of 10000 IU per kg b.w. of chole-
calciferol (group A, n = 8) or 40000 IU per kg b.w.
of cholecalciferol (group B, n = 8) were given daily
for 5 consecutive days at the same time of day
(10:00 am) in 0.2 ml of saline solution. The control
group (n = 8) received physiological saline at the
same rate and volume. Individuals were randomly
assigned to each group. The animals tolerated the
applied doses of cholecalciferol well and remained
in good condition throughout the duration of the
experiment. Measurements of free H2S concentra-
tions were performed using the modified method
of Siegel (SIEGEL 1965; SOMOGYI et al. 2008).
The study was performed in accordance to the
guidelines for the care and use of laboratory ani-
mals accepted by the Bioethical Committee of the
Jagiellonian University Medical College (Kraków,
Poland).
Tissue sample preparation
Two hours after the last drug or physiological sa-
line injection, the animals were killed by cervical
dislocation. The brain, heart and kidney tissues of
each animal were quickly removed, homogenized
with 0.01 M sodium hydroxide (NaOH) and fro-
zen. Each tissue was combined with NaOH in dif-
ferent proportions (brain: 1 to 4, kidney: 1 to 5 and
heart: 1 to 10). Then 50% trichloroacetic acid (TCA)
was added to the samples. The TCA solution (0.5
ml) was added to 2 g of brain samples in tight 3 ml
capsules, and 0.25 ml was added to 1 g of heart or
kidney sample in tight 2 ml capsules. These sus-
pensions were shaken, and the resultant mixture
was centrifuged. Subsequently, 1.5 ml brain and
0.75 ml heart or kidney supernatant samples were
moved to 2 ml tight capsules with 0.15 ml or 0.075
ml of 0.02 M N,N-dimethyl-p-phenyldiamine sul-
fate in 7.2 M hydrochloric acid (HCl), and 0.15 ml
or 0.075 ml of 0.03 M iron (III) chloride (FeCl3),
respectively, was then added in 1.2 M HCl por-
tions. After 20 min in the dark, the contents were
shaken for 1 min with 1 ml of chloroform.
H2S tissue concentration measurements
Absorbance was measured at 650 nm with a Var-
ian Cary 100 spectrophotometer. A standard curve
was prepared with an iodometrically determined
0.0001 M sodium sulfide (Na2S) solution. Four
concurrent analyses of every analyzed tissue type
were performed for each group of animals.
Statistical analysis
Statistical analysis was performed within the R
Environment by the Student’s t-test and univariate
analysis of variance (ANOVA). Statistical signifi-
cance was considered when P<0.05.
Results and Discussion
There was a significant progressive increase in
the H2S concentration along with the rising chole-
calciferol doses as compared to the control group
in the heart (by 29.6% and by 74.1%, respec-
tively). Higher vitamin D3 dose caused tissue H2S
accumulation in the brain (by 10.9%) and in the
kidney (by 10.1%). The free H2S tissue levels are
presented in Table 1.
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Table 1
Hydrogen sulfide (H2S) tissue concentrations in mouse brain, heart and kidney following
the administration of 10000 IU/kg b.w. per day or 40000 IU/kg b.w. per day of cholecalcif-
erol (groups A and B, respectively)
Tissue type
H2S tissue concentration [Fg/g] ANOVA
Control group (n = 8) Group A (n = 8) Group B (n = 8)
Brain 2.21 ± 0.02 2.25 ± 0.04 2.49 ± 0.07 F(2, 9) = 40.5; P<0.001
Heart 11.00 ± 0.18 14.26 ± 0.11* 19.15 ± 0.44 F(2, 9) = 854.2; P<0.001
Kidney 6.35 ± 0.10 6.44 ± 0.15 6.99 ± 0.11 F(2, 9) = 31.8; P<0.001
Statistical significance: *p<0.001 for Control group vs D1 group; P<0.001 for Control vs D2 group.
H2S is formed from cysteine and homocysteine
in several enzymatic reactions catalyzed by cystathio-
nineâ-synthase (CBS), cystathionine ã-lyase (CSE)
and 3-mercaptopyruvate sulfurtransferase (3MST)
along with cysteine aminotransferase (CAT), and
in non-enzymatic pathways in many tissues (KIMURA
2011). Enzymes participating in its production
have been localized i.a. in heart, brain, liver, kidney,
lung, vessels including aorta and portal vein, pan-
creatic islets, placenta, thymus and testis. Apart
from free H2S presence in tissues, organized stores
for the messenger in cells have been identified.
Cytoplasmatic bound sulfane sulfur is postulated
to absorb and store exogenously applied and endoge-
nously produced H2S, which releases H2S under
reducing conditions – the presence of glutathione
and cysteine at pH 8.4. The second H2S store con-
sists of mitochondria acid-labile sulfur – sulfur at-
oms of redox reactions catalyzed by enzymes of
the respiratory chain. H2S is released below the
critical pH 5.4 achieved locally in those organelles
(ISHIGAMI et al. 2009; OGASAWARA et al. 1994).
The method applied in our experiment traces the
changes of free H2S upon certain interventions.
The sampled tissues contain all sorts of H2S. Im-
mediate alkalization prevents loss of free H2S
through binding it into salt. Obviously, under these
circumstances hydrolysis and the transformation
of other forms of sulfane into free H2S might take
place, but rapid freezing efficiently limits the process.
Alkalization and refrigeration are necessary for
maintaining free H2S until the moment of analysis.
Acidification of a sample during the process of
H2S analysis releases the bound into salt, but ini-
tially free, H2S. It should be noted that samples
were not incubated for a sufficient amount of time
in temperatures above zero that would allow other
forms of H2S to transform into free H2S, as applied
in the study of Ishigami and colleagues (2009) to
determine acid-labile sulfur. Such a process can
not be excluded but its impact on the final results is
eliminated by the use of blank determinations.
H2S is lipophilic, freely permeates plasma mem-
branes, has pronounced reducing activity and par-
ticipates in the sulfhydration of numerous proteins,
altering their function, posing an important physi-
ologic signal (GADALLA & SNYDER 2010). The
gasotransmitter interacts with carbon monoxide
(CO) and nitric oxide (NO) in a number of ways
(LI et al. 2009). H2S has multidirectional actions
(Table 2) and co-modulates various physiological
and pathophysiological processes of different sys-
tems in mammals (LI et al. 2011; LI et al. 2009;
£OWICKA&BE£TOWSKI2007;WILIÑSKIetal.2010).
Vitamin D3 exerts a large number of biological
effects reaching beyond calcium and phosphate
metabolism, comprising modulation of immunity,
inflammation, cell differentiation and prolifera-
tion or insulin secretion (DI ROSA et al. 2011).
Moreover, cholecalciferol has been shown to be im-
plicated in the pathophysiology of such diseases as
hypertension, heart failure, chronic kidney disease,
diabetes and dementia (VAIDYA & WILLIAMS
2011). These disorders are characterized by en-
dogenous sulfur metabolism perturbances and are
extensively studied as concerns the role of H2S in
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Table 2
Biological actions of hydrogen sulfide in mammals
protein sulfhydration interaction with nitric oxide (NO)and carbon monoxide (CO)
maintaining protein –SH groups




(cytochrome c blockade) smooth muscle cell hyperpolarization
reaction with reactive oxygen
and nitrogen species
(ROS and RNS)
stimulation of cysteine transport
to the cell and reduced glutathione (GSH)
synthesis
impact on pro-inflammatory cytokine
production
TRP channel stimulation
(i.a. TRPV1 channel opening)
inhibition of L-type, T-type
and M-type calcium channels enhancement of NMDA receptor activity
impact on protein kinase C
(PKC)
influence on extracellular signal-regulated
kinases inhibition of phosphodiesterases
CFTR channel activation impact on phosphoinositide 3’-kinase(PI3K)/Akt (protein kinase B)
leukocyte-endothelial cell interaction
decrease
modification of matrix metallo-
proteinases activity
(i.a. MMP-2 and MMP-9)
effect on NF-E2-related factor-2 (Nrf-2) inhibition of angiotensin-convertingenzyme (ACE)
membrane potential stabilization influence on NF-êB complex activation promotion of Ca2+ influx into astrocytes
CFTR – cystic fibrosis transmembrane conductance regulator, NF-êB – nuclear factor kappa-light-chain-enhancer of activated
B cells, NMDA – N-Methyl-D-aspartate, TRP channel – transient receptor potential channel, TRPV1 – transient receptor
potential vanilloid.
their treatment (£OWICKA & BE£TOWSKI 2007).
In its biological action vitamin D3 binds to specific
receptors (VDR) and Retinoid X receptor-á (RXR-á)
in the nucleus of various cells of the body, alto-
gether binding to a specific DNA sequence, then
the complex regulates the expression of different
genes. Additionally, ‘cross-talking’ to other signaling
pathways and some intracellular ‘rapid’ signaling
pathways have been identified (ARANDA & PASCUAL
2001). They explain the complex outcome to a cer-
tain extent, but some biological effects of cholecal-
ferol are possibly mediated by different messangers.
Various features and molecular aspects of vitamin
D3 and H2S are common such as production at the
inflammation site, the involvement of calcium
channels, NO, renin-angiotensin-aldosterone sys-
tem, prostaglandin E and extracellular signal-
regulated kinases (ERKs), antioxidant properties,
matrix metalloproteinase activity regulation or im-
pact on cholesterol metabolism (DI ROSA et al. 2011;
KIMURA 2011; LAGGNER et al. 2007; VAIDYA &
WILLIAMS 2011; WILIÑSKI et al. 2010). Experi-
mental data on anti-atherosclerotic, hypotensive,
anti-proliferative and anti-cancer effects also con-
nect both compounds (KRISHNAN & FELDMAN 2011;
£OWICKA & BE£TOWSKI 2007; MASON et al.
2003; PEI et al. 2011). The interaction mechanisms
remain obscure with NO as a probable link be-
tween vitamin D and endogenous sulfur biology,
as the impact of cholecalciferol on nitric oxide
synthase was revealed (ROCKETT et al. 1998). It is
worth mentioning that other drugs were also shown
to affect the complex sulfur metabolism and H2S
including acetylsalicylic acid, 3-hydroxy-3-methyl-
glutaryl-coenzyme A (HMG-CoA) inhibitor ator-
vastatin, ACE inhibitor ramipril, digoxin and
paracetamol and the non-selective â-blocker carve-
dilol (SREBRO et al. 2006, WILIÑSKI et al. 2011a;
WILIÑSKI et al. 2011b; WILIÑSKI et al. 2011c;
WILIÑSKI et al. 2011d; WILIÑSKI et al. 2010).
In conclusion, our study reveals the existence of
a link between vitamin D biology and endogenous
sulfur metabolism, appraised by H2S bioavailabil-
ity. The presented results are highly indicative but
less conclusive. The involvement of H2S throws
some light on the complexity of vitamin D biol-
ogy. The impact of cholecalciferol on CBS, CSE
and 3MST gene expression has never been ex-
plored. The biological effects of vitamin D3 fol-
lowing the inhibition of H2S production have not
been assessed. These issues and the role of vitamin
D and H2S in cardiology, nephrology and neurol-
ogy are promising fields for future research.
References
ARANDA A., PASCUAL A. 2001. Nuclear hormone receptors
and gene expression. Physiol. Rev. 81: 1269-304.
DI ROSA M., MALAGUARNERA M., NICOLETTI F.,
MALAGUARNERA L. 2011. Vitamin D3: a helpful immuno-
modulator. Immunology 134: 123-139.
GADALLA M. M., SNYDER S. H. 2010. Hydrogen sulfide as a
gasotransmitter. J. Neurochem. 113: 14-26.
ISHIGAMI M., HIRAKI K., UMEMURA K., OGASAWARA Y.,
ISHIIK., KIMURAH. 2009. A source of hydrogen sulfide and
a mechanism of its release in the brain. Antioxid. Redox.
Signal. 11: 205-214.
KIMURA H. 2011. Hydrogen sulfide: its production, release
and functions. Amino Acids 41: 113-121.
KRISHNAN A. V., FELDMAN D. Mechanisms of the anti-
cancer and anti-inflammatory actions of vitamin D. Annu.
Rev. Pharmacol. Toxicol. 51: 311-336.
LAGGNER, H., HERMANN M., ESTERBAUER H., MUELLNER
M. K., EXNER M., GMEINER B. M., KAPIOTIS S. 2007. The
novel gaseous vasorelaxant hydrogen sulfide inhibits
angiotensin-converting enzyme activity of endothelial cells.
J. Hypertens. 25: 2100-2104.
LEE Z. W., ZHOU J., CHEN C. S., ZHAO Y., TAN C. H., LI L.,
MOORE P. K., DENG L. W. 2011. The slow-releasing hydro-
gen sulfide donor, GYY4137, exhibits novel anti-cancer ef-
fects in vitro and in vivo. PLoS One 6: e21077.
LIL., HSUA., MOORE P. K. 2009. Actions and interactions of
nitric oxide, carbon monoxide and hydrogen sulphide in the
cardiovascular system and in inflammation-a tale of three
gases! Pharmacol. Ther. 123: 386-400.
LIL., ROSE P., MOORE P. K. 2011. Hydrogen sulfide and cell
signaling. Annu. Rev. Pharmacol. Toxicol. 51: 169-187.
LISS Y., FRISHMAN W. H. 2012. Vitamin D: a cardioprotec-
tive agent? Cardiol. Rev. 20: 38-44.
£OWICKA E., BE£TOWSKI J. 2007. Hydrogen sulfide (H2S) –
the third gas of interest for pharmacologists. Pharmacol.
Rep. 59: 4-24.
MASON R. P., MARCHE P., HINTZE T. H. 2003. Novel vascu-
lar biology of third-generation L-type calcium channel an-
tagonists: ancillary actions of amlodipine. Arterioscler.
Thromb. Vasc. Biol. 23: 2155-2163.
OGASAWARA Y., ISODA S., TANABE S. 1994. Tissue and sub-
cellular distribution of bound and acid-labile sulfur, and the
enzymic capacity for sulfide production in the rat. Biol.
Pharm. Bull. 17: 1535-1542.
PEIY., WUB., CAOQ., WUL., YANGG. 2011. Hydrogen sul-
fide mediates the anti-survival effect of sulforaphane on hu-
man prostate cancer cells. Toxicol. Appl. Pharmacol. 257:
420-428.
PREDMORE B. L., LEFER D. J. 2010. Development of hydro-
gen sulfide-based therapeutics for cardiovascular disease. J
Cardiovasc. Transl. Res. 3: 487-498.
ROCKETT K. A., BROOKES R., UDALOVA I., VIDAL V., HILL
A. V., KWIATKOWSKI D. 1998. 1,25-Dihydroxyvitamin D3
induces nitric oxide synthase and suppresses growth of My-
cobacterium tuberculosis in a human macrophage-like cell
line. Infect. Immun. 66: 5314-5321.
SIEGEL L. M. 1965. A Direct Microdetermination for Sulfide.
Anal. Biochem. 11: 126-132.
SOMOGYI E., PIOTROWSKA J., RZESZUTKO W. 2008. An ef-
fect of some parameters of the determination of the hydrogen
sulfide in pig liver and brain on the obtained results. Farm.
Prz. Nauk. 5: 33-36. (in Polish with English summary).
SREBRO Z., SOMOGYI E., WILIÑSKI B., GÓRALSKA M.,
WILIÑSKI J., SURA P. 2006. Aspirin augments the concen-
tration of endogenous hydrogen sulfide in mouse brain and
liver. Folia Med. Cracov. 47: 87-91.
VAIDYA A., WILLIAMS J. S. 2012. The relationship between
vitamin D and the renin-angiotensin system in the patho-
physiology of hypertension, kidney disease, and diabetes.
Metabolism 61: 450-458.
WELSH J. 2012. Cellular and molecular effects of vitamin D on
carcinogenesis. Arch. Biochem. Biophys. 523: 107-114.
B. WILIÑSKI et al.246
WILIÑSKI B., WILIÑSKI J, SOMOGYI E., GÓRALSKA M.,
PIOTROWSKA J. 2010. Ramipril affects hydrogen sulfide
g.eneration in mouse liver and kidney. Folia Biol. (Kraków)
3-4: 177-180.
WILIÑSKI B., WILIÑSKI J., SOMOGYI E., GÓRALSKA M.,
PIOTROWSKA J. 2011. Paracetamol (acetaminophen) de-
creases hydrogen sulfide tissue concentration in brain and
increases in the heart, liver and kidney in mice. Folia Biol.
(Kraków) 59: 41-44.
WILIÑSKI B., WILIÑSKI J., SOMOGYI E., PIOTROWSKA J.,
GÓRALSKA M. 2010. Amlodipine affects endogenous hy-
drogen sulfide tissue concentrations in different mouse or-
gans. Folia Med. Cracov. 1-4: 29-35.
WILIÑSKI B., WILIÑSKI J., SOMOGYI E., PIOTROWSKA J.,
GÓRALSKA M. 2011. Atorvastatin affects the hydrogen
sulfide tissue concentration in mouse kidneys and other or-
gans. Pharmacol. Rep. 63: 184-188.
WILIÑSKI B., WILIÑSKI J., SOMOGYI E., PIOTROWSKA J.,
GÓRALSKA M. 2011. Digoxin increases hydrogen sulfide
concentrations in brain, heart and kidney tissues in mice.
Pharmacol. Rep. 63: 1243-1247.
WILIÑSKI B., WILIÑSKI J., SOMOGYI E., PIOTROWSKA J.,
GÓRALSKA M., MACURA B. 2011. Carvedilol induces en-
dogenous hydrogen sulfide tissue concentration changes in
various mouse organs. Folia Biol. (Kraków) 59: 151-155.
Cholecalciferol and Endogenous Hydrogen Sulfide 247
